MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health ROE Ratio 2011-2026 | OPK
Annual ROE Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.03 | -4.79 | -21.03 | -1.79 | 1.83 | -19.5 | -8.54 | -16.38 | -1.2 | -1.52 | -20.38 | -13.05 | -14.26 | -0.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.83 | -21.03 | -8.6 |
Quarterly ROE Ratio OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.57 | -10.65 | -11.34 | -14.4 | -14.84 | -13.59 | -13.03 | -17.66 | -14.63 | -19.01 | -12.1 | -7.11 | -1.85 | 4.46 | 4.25 | 7.2 | 1.83 | -7.06 | -12.32 | -18.04 | -19.5 | -16.79 | -14.5 | -11.14 | -8.54 | -16.12 | -16.51 | -17.07 | -16.53 | -5.77 | -4.55 | -2.9 | -1.61 | -0.47 | 6.76 | 0.84 | -12.99 | -19.42 | -31.7 | -29.55 | -20.44 | -16.08 | -17.15 | -14.51 | -13.13 | -11.75 | -10.29 | -15.61 | -16.51 | -4.77 | -4.51 | -2.37 | -1.12 | -5.12 | -3.57 | -3.55 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.2 | -31.7 | -10.43 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
22.45 | $ 120.47 | 1.2 % | $ 36.6 B |  USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.9 | 2.47 % | $ 94.1 K | USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 22.13 | -5.98 % | $ 243 M |  China |
 |
Celcuity
CELC
|
-96.68 | $ 108.86 | 1.36 % | $ 4.29 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
4.0 | $ 27.97 | 1.43 % | $ 777 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.17 | 2.72 % | $ 428 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 179.12 | 1.95 % | $ 8.88 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 638.42 | 0.62 % | $ 51.3 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 131.73 | 1.67 % | $ 20.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 282.44 | -0.19 % | $ 23.5 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 79.34 | 0.63 % | $ 5.35 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-205.65 | $ 15.04 | -2.97 % | $ 1.95 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 319.33 | 0.2 % | $ 27.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.43 | 2.65 % | $ 503 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.65 | 1.1 % | $ 1.24 B | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.12 | - | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 209.29 | 0.44 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 204.98 | 0.48 % | $ 146 B | USA |
 |
National Research Corporation
NRC
|
63.26 | $ 13.39 | - | $ 329 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.46 | 0.09 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
-90.0 | $ 8.57 | -1.95 % | $ 537 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.5 | 1.94 % | $ 298 M | Israel |
 |
DexCom
DXCM
|
30.46 | $ 71.55 | -2.09 % | $ 27.9 B | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.62 | 6.25 % | $ 486 M | USA |
 |
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 111.03 | 2.14 % | $ 9.16 B |  Irlanda |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
-40.56 | $ 25.4 | 1.7 % | $ 33 M | USA |
 |
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 19.2 | 2.13 % | $ 1.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |